Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Genmab Current Ratio 2019-2020 | GMAB

Current and historical current ratio for Genmab (GMAB) from 2019 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Genmab current ratio for the three months ending March 31, 2020 was 19.04.
  
Genmab Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $2.08B $0.11B 19.04
2019-12-31 $2.09B $0.14B 14.88
2019-09-30 $1.83B $0.10B 18.72
2019-06-30 $1.18B $0.08B 14.89
2019-03-31 $0.00B 0.00
2018-12-31 $1.18B $0.07B 16.77
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $22.443B $0.805B
Genmab A/S is a biotechnology company. It specializes in development of antibody therapeutics for the treatment of cancer. The company's product pipeline includes DARZALEX(R), Arzerra(R), tisotumab vedotin, enapotamab vedotin, HexaBody-DR5/DR5(R) and DuoBody-CD3xCD20 (R),which are in clinical stage. Genmab A/S is based in Copenhagen V, Denmark.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $148.915B 16.40
Bristol Myers Squibb (BMY) United States $136.418B 11.40
Gilead Sciences (GILD) United States $95.859B 12.43
CSL (CSLLY) Australia $91.400B 0.00
Vertex Pharmaceuticals (VRTX) United States $77.539B 53.31
Regeneron Pharmaceuticals (REGN) United States $70.508B 27.18
Illumina (ILMN) United States $54.702B 56.21
Biogen (BIIB) United States $43.791B 7.50
Seattle Genetics (SGEN) United States $30.490B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.834B 10.67
Incyte (INCY) United States $23.618B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $23.288B 0.00
BioMarin Pharmaceutical (BMRN) United States $23.144B 209.80
Moderna (MRNA) United States $22.678B 0.00
Genmab (GNMSF) Denmark $21.119B 62.70
Alnylam Pharmaceuticals (ALNY) United States $18.457B 0.00
BioNTech SE (BNTX) Germany $15.689B 0.00
BeiGene (BGNE) Cayman Islands $15.289B 0.00
Galapagos (GLPG) Belgium $13.179B 38.77
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
Exact Sciences (EXAS) United States $12.938B 0.00
Sarepta Therapeutics (SRPT) United States $12.782B 0.00
ARGENX SE-ADR (ARGX) Netherlands $11.536B 0.00
Horizon Therapeutics Public (HZNP) Ireland $10.930B 26.90
Bio-Techne Corp (TECH) United States $10.196B 67.36
QIAGEN (QGEN) Netherlands $9.837B 28.60
Immunomedics (IMMU) United States $9.504B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.884B 0.00
Guardant Health (GH) United States $8.066B 0.00
Exelixis (EXEL) United States $7.167B 25.13
Ascendis Pharma (ASND) Denmark $7.083B 0.00
Repligen (RGEN) United States $6.493B 113.89
Novavax (NVAX) United States $6.060B 0.00
Adaptive Biotechnologies (ADPT) United States $5.907B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.664B 121.88
Acceleron Pharma (XLRN) United States $5.535B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.242B 0.00
Vir Biotechnology (VIR) United States $5.229B 0.00
Reata Pharmaceuticals (RETA) United States $5.173B 0.00
Mirati Therapeutics (MRTX) United States $5.123B 0.00
Zai Lab (ZLAB) China $4.812B 0.00
Emergent Biosolutions (EBS) United States $4.691B 30.75
MyoKardia (MYOK) United States $4.390B 0.00
MorphoSys AG (MOR) Germany $4.341B 33.67
China Biologic Products (CBPO) China $4.210B 23.40
Blueprint Medicines (BPMC) United States $4.183B 0.00
Amicus Therapeutics (FOLD) United States $4.094B 0.00
Global Blood Therapeutics (GBT) United States $4.077B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.974B 0.00
Inovio Pharmaceuticals (INO) United States $3.809B 0.00
Halozyme Therapeutics (HALO) United States $3.774B 0.00
NeoGenomics (NEO) United States $3.727B 272.15
Bluebird Bio (BLUE) United States $3.577B 0.00
Arena Pharmaceuticals (ARNA) United States $3.212B 0.00
Alkermes (ALKS) Ireland $3.189B 62.78
Deciphera Pharmaceuticals (DCPH) United States $3.067B 0.00
Fate Therapeutics (FATE) United States $2.915B 0.00
Denali Therapeutics (DNLI) United States $2.813B 0.00
Insmed (INSM) United States $2.794B 0.00
Amarin (AMRN) Ireland $2.598B 0.00
PHARMA MAR SA (PHMMF) Spain $2.479B 0.00
Viela Bio (VIE) United States $2.157B 0.00
UniQure (QURE) Netherlands $2.027B 0.00
Twist Bioscience (TWST) United States $2.000B 0.00
Eidos Therapeutics (EIDX) United States $1.917B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.903B 0.00
Principia Biopharma (PRNB) United States $1.877B 0.00
Alector (ALEC) United States $1.858B 0.00
Editas Medicine (EDIT) United States $1.777B 0.00
Ligand Pharmaceuticals (LGND) United States $1.762B 68.62
Zymeworks (ZYME) Canada $1.759B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.708B 0.00
I-Mab (IMAB) China $1.680B 0.00
Adverum Biotechnologies (ADVM) United States $1.644B 0.00
Epizyme (EPZM) United States $1.630B 0.00
Intra-Cellular Therapies (ITCI) United States $1.614B 0.00
Mersana Therapeutics (MRSN) United States $1.562B 0.00
Cytokineticsorporated (CYTK) United States $1.549B 0.00
Sorrento Therapeutics (SRNE) United States $1.548B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.495B 0.00
Mesoblast (MESO) Australia $1.484B 0.00
Sangamo Therapeutics (SGMO) United States $1.482B 0.00
Beam Therapeutics (BEAM) United States $1.473B 0.00
Zealand Pharma (ZEAL) Denmark $1.464B 0.00
Revance Therapeutics (RVNC) United States $1.459B 0.00
Akcea Therapeutics (AKCA) United States $1.420B 0.00
REGENXBIO (RGNX) United States $1.404B 0.00
Zealand Pharma (ZLDPF) Denmark $1.369B 0.00
NGM Biopharmaceuticals (NGM) United States $1.361B 0.00
Arvinas (ARVN) United States $1.307B 0.00
Coherus BioSciences (CHRS) United States $1.269B 8.86
Adaptimmune Therapeutics (ADAP) United Kingdom $1.259B 0.00
Intellia Therapeutics (NTLA) United States $1.235B 0.00
NantKwest (NK) United States $1.208B 0.00
Arcus Biosciences (RCUS) United States $1.166B 0.00
Athenex (ATNX) United States $1.086B 0.00
Compugen (CGEN) Israel $1.082B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.000B 0.00
Alcobra (ARCT) United States $0.988B 0.00
Retrophin (RTRX) United States $0.902B 0.00
Myriad Genetics (MYGN) United States $0.862B 44.46
Heska (HSKA) United States $0.852B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Pharming Group (PHGUF) Netherlands $0.826B 22.00
Cara Therapeutics (CARA) United States $0.819B 0.00
Dynavax Technologies (DVAX) United States $0.813B 0.00
Morphic Holding (MORF) United States $0.776B 0.00
VBI Vaccines (VBIV) United States $0.775B 0.00
Intrexon (PGEN) United States $0.775B 0.00
Kadmon Holdings (KDMN) United States $0.757B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.738B 0.00
Codexis (CDXS) United States $0.727B 0.00
Castle Biosciences (CSTL) United States $0.704B 0.00
Frequency Therapeutics (FREQ) United States $0.696B 0.00
Cellectis S.A (CLLS) France $0.693B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.689B 0.00
Agenus (AGEN) United States $0.670B 0.00
Vericel (VCEL) United States $0.662B 122.33
Cue Biopharma (CUE) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Vanda Pharmaceuticals (VNDA) United States $0.629B 5.39
AnaptysBio (ANAB) United States $0.618B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.605B 0.00
MiMedx (MDXG) United States $0.597B 0.00
Kala Pharmaceuticals (KALA) United States $0.583B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.557B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.557B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.545B 0.00
Athersys (ATHX) United States $0.540B 0.00
Syros Pharmaceuticals (SYRS) United States $0.529B 0.00
Cel-Sci (CVM) United States $0.519B 0.00
Anika Therapeutics (ANIK) United States $0.512B 16.48
NextCure (NXTC) United States $0.512B 0.00
Scholar Rock Holding (SRRK) United States $0.509B 0.00
UROGEN PHARMA (URGN) United States $0.509B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.508B 0.00
Clovis Oncology (CLVS) United States $0.506B 0.00
Protagonist Therapeutics (PTGX) United States $0.503B 0.00
DBV Technologies S.A (DBVT) France $0.502B 0.00
AC Immune SA (ACIU) Switzerland $0.492B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.467B 0.00
Merus (MRUS) Netherlands $0.450B 0.00
Geron (GERN) United States $0.445B 0.00
MeiraGTx Holdings (MGTX) United States $0.443B 0.00
BioDelivery Sciences (BDSI) United States $0.437B 22.95
Precision BioSciences (DTIL) United States $0.429B 0.00
Prothena (PRTA) Ireland $0.427B 0.00
Puma Biotechnology (PBYI) United States $0.426B 0.00
Seres Therapeutics (MCRB) United States $0.409B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.406B 0.00
Avid Bioservices (CDMO) United States $0.390B 0.00
MannKind (MNKD) United States $0.386B 0.00
Albireo Pharma (ALBO) United States $0.383B 0.00
CytomX Therapeutics (CTMX) United States $0.378B 0.00
ANI Pharmaceuticals (ANIP) United States $0.371B 7.35
Kamada (KMDA) Israel $0.369B 15.33
WAVE Life Sciences (WVE) Singapore $0.344B 0.00
PDL BioPharma (PDLI) United States $0.335B 287.50
Affimed (AFMD) Germany $0.335B 0.00
OSMOTICA PHARM (OSMT) United States $0.330B 0.00
Cellular Biomedicine (CBMG) United States $0.318B 0.00
Starpharma Holdings (SPHRY) Australia $0.313B 0.00
Prometic Life Sciences (LMNL) Canada $0.309B 0.00
Menlo Therapeutics (MNLO) United States $0.290B 0.00
Abeona Therapeutics (ABEO) United States $0.285B 0.00
Celldex Therapeutics (CLDX) United States $0.284B 0.00
Pfenex (PFNX) United States $0.283B 0.00
Spero Therapeutics (SPRO) United States $0.282B 0.00
ChromaDex (CDXC) United States $0.280B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.278B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.270B 0.00
IBio (IBIO) United States $0.266B 0.00
IVERIC Bio (ISEE) United States $0.256B 0.00
ADMA Biologics Inc (ADMA) United States $0.254B 0.00
Northwest Biotherapeutics (NWBO) United States $0.254B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.248B 0.00
Dyadic (DYAI) United States $0.244B 0.00
Verastem (VSTM) United States $0.244B 0.00
Selecta Biosciences (SELB) United States $0.241B 0.00
Gritstone Oncology (GRTS) United States $0.236B 0.00
HOOKIPA Pharma (HOOK) United States $0.234B 0.00
Fortress Biotech (FBIO) United States $0.231B 0.00
Five Prime Therapeutics (FPRX) United States $0.228B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.223B 0.00
Liquidia Technologies (LQDA) United States $0.223B 0.00
XOMA (XOMA) United States $0.220B 0.00
Pluristem Therapeutics (PSTI) Israel $0.218B 0.00
Aptinyx (APTX) United States $0.216B 0.00
Aduro Biotech (ADRO) United States $0.212B 0.00
GENFIT S.A (GNFT) France $0.211B 0.00
Exicure (XCUR) United States $0.207B 0.00
Strongbridge Biopharma (SBBP) United States $0.207B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.203B 3.06
Bellus Health (BLU) Canada $0.200B 0.00
Sutro Biopharma (STRO) United States $0.195B 0.00
POXEL SA FRANCE (PXXLF) France $0.194B 0.00
ARAVIVE, INC (ARAV) United States $0.193B 0.00
Trevena (TRVN) United States $0.175B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.174B 0.00
Aytu Bioscience (AYTU) United States $0.162B 0.00
Theratechnologies (THTX) Canada $0.159B 0.00
Cidara Therapeutics (CDTX) United States $0.157B 0.00
Cerecor (CERC) United States $0.156B 0.00
Kindred Biosciences (KIN) United States $0.152B 0.00
Cyclerion Therapeutics (CYCN) United States $0.151B 0.00
CorMedix Inc (CRMD) United States $0.149B 0.00
VTv Therapeutics (VTVT) United States $0.149B 0.00
TELA Bio (TELA) United States $0.145B 0.00
Applied Genetic Technologies (AGTC) United States $0.145B 0.00
Celyad SA (CYAD) Belgium $0.141B 0.00
Biofrontera AG (BFRA) Germany $0.139B 0.00
VolitionRX (VNRX) United States $0.138B 0.00
PHASEBIO PHARMA (PHAS) United States $0.136B 0.00
Lumos Pharma (LUMO) United States $0.132B 0.00
Orgenesis (ORGS) United States $0.131B 0.00
Arbutus Biopharma (ABUS) United States $0.128B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.123B 0.00
Celsion (CLSN) United States $0.121B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.121B 0.00
Oncobiologics (OTLK) United States $0.120B 0.00
Palatin Technologies (PTN) United States $0.119B 3.05
Enzo Biochem (ENZ) United States $0.119B 0.00
Protalix BioTherapeutics (PLX) Israel $0.117B 0.00
AIT Therapeutics (XAIR) United States $0.116B 0.00
Eton Pharmaceuticals (ETON) United States $0.112B 0.00
AquaBounty Technologies (AQB) United States $0.104B 0.00
Checkpoint Therapeutics (CKPT) United States $0.097B 0.00
Cardiff Oncology (CRDF) United States $0.097B 0.00
Windtree Therapeutics (WINT) United States $0.096B 0.00
DiaMedica Therapeutics (DMAC) United States $0.095B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.092B 0.00
Emmaus Life Sciences (EMMA) United States $0.089B 0.00
Antibe Therapeutics (ATBPF) Canada $0.087B 0.00
Clearside Biomedical (CLSD) United States $0.085B 0.00
Cocrystal Pharma (COCP) United States $0.083B 0.00
Organovo Holdings (ONVO) United States $0.083B 0.00
Adocia (ADOCY) France $0.080B 0.00
SESEN BIO, INC (SESN) United States $0.078B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.078B 0.00
Unum Therapeutics (UMRX) United States $0.074B 0.00
Catalyst Biosciences (CBIO) United States $0.072B 0.00
Proteostasis Therapeutics (PTI) United States $0.071B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.070B 0.00
Happiness Biotech Group (HAPP) China $0.069B 0.00
AnPac Bio-Medical Science (ANPC) China $0.069B 0.00
Synlogic (SYBX) United States $0.068B 0.00
Stealth BioTherapeutics (MITO) United States $0.065B 0.00
Vaccinex (VCNX) United States $0.062B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Idera Pharmaceuticals (IDRA) United States $0.059B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.057B 0.00
Signal Genetics (MGEN) United States $0.056B 0.00
Soligenix (SNGX) United States $0.054B 0.00
CollPlant Holdings (CLGN) Israel $0.054B 0.00
Vascular Biogenics (VBLT) Israel $0.053B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.052B 0.00
Pulmatrix (PULM) United States $0.047B 0.00
Apricus Biosciences (SEEL) United States $0.046B 0.00
Edesa Biotech (EDSA) Canada $0.044B 0.00
AmpliPhi Biosciences (ARMP) United States $0.044B 0.00
Curis (CRIS) United States $0.043B 0.00
Prima BioMed (IMMP) Australia $0.041B 0.00
Bionano Genomics (BNGO) United States $0.040B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
Advaxis (ADXS) United States $0.034B 0.00
Cesca Therapeutics (THMO) United States $0.034B 0.00
Chanticleer Holdings (SONN) United States $0.032B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.031B 0.00
OvaScience (MLND) United States $0.031B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Spherix (AIKI) United States $0.030B 0.00
Alimera Sciences (ALIM) United States $0.029B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Evogene (EVGN) Israel $0.028B 0.00
BioPharmX (TMBR) United States $0.027B 0.00
Novogen (KZIA) Australia $0.027B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
IMMURON (IMRN) Australia $0.026B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
FORTE BIOSCIENC (FBRX) United States $0.024B 0.00
Prana Biotechnology (ATHE) Australia $0.022B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.021B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
BioCardia (BCDA) United States $0.016B 0.00
MYOS RENS Technology (MYOS) United States $0.016B 0.00
VIVUS (VVUS) United States $0.014B 0.00
Neuralstem (SNCA) United States $0.014B 0.00
AEterna Zentaris (AEZS) United States $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00